Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhibition of LRRK2 kinase activity promotes anterograde axonal transport and presynaptic targeting of α-synuclein
Charlotte F. Brzozowski, Baraa Hijaz, Vijay P. Singh, et al.
Acta Neuropathologica Communications (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 20

Showing 20 citing articles:

LRRK2 suppresses lysosome degradative activity in macrophages and microglia through MiT-TFE transcription factor inhibition
Narayana Yadavalli, Shawn M. Ferguson
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 31
Open Access | Times Cited: 33
Small-molecule LRRK2 inhibitors for PD therapy: Current achievements and future perspectives
Jiarui Hu, Dan Zhang, Keyue Tian, et al.
European Journal of Medicinal Chemistry (2023) Vol. 256, pp. 115475-115475
Closed Access | Times Cited: 27
RAB3 phosphorylation by pathogenic LRRK2 impairs trafficking of synaptic vesicle precursors
Dan Dou, Jayne Aiken, Erika L.F. Holzbaur
The Journal of Cell Biology (2024) Vol. 223, Iss. 6
Open Access | Times Cited: 7
The Role of Rab Proteins in Parkinson’s Disease Synaptopathy
Arianna Bellucci, Francesca Longhena, Maria Grazia Spillantini
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1941-1941
Open Access | Times Cited: 23
Neuronopathic GBA1L444P Mutation Accelerates Glucosylsphingosine Levels and Formation of Hippocampal Alpha-Synuclein Inclusions
Casey L. Mahoney-Crane, Megha Viswanathan, Drèson L. Russell, et al.
Journal of Neuroscience (2022) Vol. 43, Iss. 3, pp. 501-521
Open Access | Times Cited: 21
Lysosomal dysfunction in α-synuclein pathology: molecular mechanisms and therapeutic strategies
Lijun Dai, Miao Liu, Ke Wei, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 4
Early A-synuclein aggregation decreases corticostriatal glutamate drive and synapse density
Charlotte F. Brzozowski, Harshita Challa, Nolwazi Z. Gcwensa, et al.
Neurobiology of Disease (2025), pp. 106918-106918
Open Access
A Mutual Nexus Between Epilepsy and α-Synuclein: A Puzzle Pathway
Naif H. Ali, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 12, pp. 10198-10215
Closed Access | Times Cited: 3
Secretion of VGF relies on the interplay between LRRK2 and post-Golgi v-SNAREs
Francesca Filippini, Sébastien Nola, Ahmed Zahraoui, et al.
Cell Reports (2023) Vol. 42, Iss. 3, pp. 112221-112221
Open Access | Times Cited: 8
Inhibition of Protein Aggregation and Endoplasmic Reticulum Stress as a Targeted Therapy for α-Synucleinopathy
Natalia Siwecka, Kamil Saramowicz, Grzegorz Galita, et al.
Pharmaceutics (2023) Vol. 15, Iss. 8, pp. 2051-2051
Open Access | Times Cited: 8
Inhibition of LRRK2 kinase activity rescues deficits in striatal dopamine physiology in VPS35 p.D620N knock-in mice
Mengfei Bu, Jordan Follett, Isaac Deng, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 8
DNL151, DNL201, and BIIB094: experimental agents for the treatment of Parkinson’s disease
Thomas Müller
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 9, pp. 787-792
Closed Access | Times Cited: 6
Exploring the interplay between metabolomics and genetics in Parkinson's disease: Insights from ongoing research and future avenues
Cíntia Barros Santos-Rebouças, Juliana Cordovil Cotrin, Gilson Costa dos Santos
Mechanisms of Ageing and Development (2023) Vol. 216, pp. 111875-111875
Closed Access | Times Cited: 5
Cellular and subcellular localization of Rab10 and phospho-T73 Rab10 in the mouse and human brain
Vijay Pal Singh, Marissa Menard, Geidy E. Serrano, et al.
Acta Neuropathologica Communications (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 5
How Parkinson’s Disease-Linked LRRK2 Mutations Affect Different CNS Cell Types
Hannah M. Bailey, Mark Cookson
Journal of Parkinson s Disease (2024) Vol. 14, Iss. 7, pp. 1331-1352
Open Access | Times Cited: 1
Cellular Models of Alpha-Synuclein Aggregation: What Have We Learned and Implications for Future Study
Katrina Albert, Sara Kälvälä, Vili Hakosalo, et al.
Biomedicines (2022) Vol. 10, Iss. 10, pp. 2649-2649
Open Access | Times Cited: 7
Formation of templated inclusions in a forebrain α-synuclein mouse model is independent of LRRK2
Dylan J. Dues, Yue Ma, An Phu Tran Nguyen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
The role of autophagic kinases in regulation of axonal function
Sarah H. Berth, Dominick J. Rich, Thomas E. Lloyd
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 3
Formation of templated inclusions in a forebrain α-synuclein mouse model is independent of LRRK2
Dylan J. Dues, Yue Ma, An Phu Tran Nguyen, et al.
Neurobiology of Disease (2023) Vol. 188, pp. 106338-106338
Open Access | Times Cited: 1
LRRK2 Suppresses Lysosome Degradative Activity in Macrophages and Microglia Through MiT-TFE Transcription Factor Inhibition
Narayana Yadavalli, Shawn M. Ferguson
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Page 1

Scroll to top